Related Experiment Videos
Sirolimus, a potent new immunosuppressive drug for organ transplantation
1Department of Surgery, University of Texas Medical School at Houston, Texas, USA. sstepkow@orgtx71.med.uth.tmc.edu
Annals of Transplantation
|January 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Historical Matching Strategies in Kidney Paired Donation: The 7-Year Evolution of a Web-Based Virtual Matching System.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Anti-TCRβ mAb induces long-term allograft survival by reducing antigen-reactive T cells and sparing regulatory T cells.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Molecular targets for existing and novel immunosuppressive drugs.
Expert reviews in molecular medicine·2003
New approaches to transplant immunosuppression.
Transplantation proceedings·2003
Preclinical results of sirolimus treatment in transplant models.
Transplantation proceedings·2003
Influence of Pretransplant and Posttransplant Diabetes on Long-Term Heart Transplant Outcomes.
Annals of transplantation·2026
Determinants of Lack of Consent for Deceased Organ Donation Among Nurses and Physicians: A Cross-Sectional Study.
Annals of transplantation·2026
Four Years of Clinical Experience With COVID-19 Outcomes in Heart Transplant Recipients.
Annals of transplantation·2026
Protective Effects of Quercetin and Sucrose on Cold Preservation Injury in Porcine Kidneys Donated After Cardiac Death.
Annals of transplantation·2026
Refractory Invasive Pulmonary Aspergillosis Following Treatment of Acute Rejection in a Kidney Transplant Recipient: A Case Report.
Case reports in transplantation·2026
Efficacy of Remimazolam for Anesthesia in Patients Undergoing Renal Allograft Transplantation: A Randomized Controlled Trial.
Drug design, development and therapy·2026